While the mouse Maf1 knockout does not promote tumorigenesis or add to the role of Pol III transcription in the development of cancer, the likely explanation and important insight is that not all interventions that increase Pol III synthesis are capable of increasing the level of tRNAiMet or other mature tRNAs. The gene discussed is MAF1; the disease is cancer.